| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 07/27/2005 | CN1646504A Substituted benzoxazoles and analogues as estrogenic agents |
| 07/27/2005 | CN1646497A New aryl imidazoles and related compounds as C5a receptor modulators |
| 07/27/2005 | CN1646495A Amine compounds and use thereof |
| 07/27/2005 | CN1646480A Derivatives of hydroxyphenyl, a method for preparing thereof and their pharmaceutical composition |
| 07/27/2005 | CN1646193A Bisphosphonic acid for the treatment and prevention of osteoporosis |
| 07/27/2005 | CN1646154A Albumin-fused anti-angiogenesis peptides |
| 07/27/2005 | CN1646143A Combination of a beta-2 adrenoceptor agonists and an aminosugars and their use for the treatment immunomodulatory disorders |
| 07/27/2005 | CN1646138A Novel therapeutical use of agonist ligands specific to G2A receptor |
| 07/27/2005 | CN1646137A Method for treating and preventing hyperparathyroidism |
| 07/27/2005 | CN1646133A Pharmaceutical combinations of cox-2 inhibitors and opiates |
| 07/27/2005 | CN1646131A Novel compounds |
| 07/27/2005 | CN1646130A Treatment of rheumatoid arthritis |
| 07/27/2005 | CN1646119A Therapeutic methods and compositions involving isoflav-3-ene and isoflavan structures |
| 07/27/2005 | CN1646093A Method and composition for treatment of inflammation and AIDS-associated neurological disorders |
| 07/27/2005 | CN1646070A Tissue repair matrix |
| 07/27/2005 | CN1212321C Industrial synthetising strontium salt and method of its hydrate |
| 07/27/2005 | CN1212166C Safety shield system for prefilled syringes |
| 07/27/2005 | CN1212148C External plaster for treating rheumatic arthritis |
| 07/27/2005 | CN1212141C Use of atractylodes rhizome oil in preparing medicine for osteoporosis |
| 07/27/2005 | CN1212140C Health care wine for women |
| 07/27/2005 | CN1212136C Traditional chinese medicine composition (Bushenzhuangyao Decoction) for reinforcing kidney and slrengthening lumbar and its preparing method |
| 07/27/2005 | CN1212132C Chinese medicine for treating rheumatic diseases and its preparation |
| 07/26/2005 | US6921763 Protein kinase inhibitors |
| 07/26/2005 | US6921762 Substituted indolizine-like compounds and methods of use |
| 07/26/2005 | CA2470200C Pharmaceutical composition |
| 07/26/2005 | CA2315481C Selective inhibition of aggrecanase in osteoarthritis treatment |
| 07/26/2005 | CA2285203C Compositions containing capsaicin or capsaicin analogues and a local anesthetic |
| 07/26/2005 | CA2269115C Monovalent antibody fragments |
| 07/21/2005 | WO2005066214A1 Hyaluronic acid derivative and drug containing the same |
| 07/21/2005 | WO2005066159A1 Cathepsin cysteine protease inhibitors |
| 07/21/2005 | WO2005065778A1 Cathepsin cysteine protease inhibitors |
| 07/21/2005 | WO2005065704A1 Preventive and remedy for bone disease |
| 07/21/2005 | WO2005065700A1 Life-prolonging agent comprising polished rice-origin components as the active ingredient |
| 07/21/2005 | WO2005065050A2 Bicyclic compound |
| 07/21/2005 | WO2005065015A2 Neutralizing antibodies and methods of use thereof |
| 07/21/2005 | WO2004089962A3 New carbamoyl-and thiocarbamoyl-phosphonates and pharmaceutical compositions comprising them |
| 07/21/2005 | US20050159491 Cerebrovascular and cardiovascular diseases; hot water extracting danshen plant and chromatographic separation on polyamide column; high yield, low cost, quality |
| 07/21/2005 | US20050159474 Chemical compounds |
| 07/21/2005 | US20050159467 5-Aryltetrazole compounds and uses thereof |
| 07/21/2005 | US20050159463 5-methoxy-3-(2-(2-furamido) ethyl)indole; related to melatonin, but pharmacologicaly and pharmacokineticy different; longer duration, selective localization and greater efficacy |
| 07/21/2005 | US20050159456 Method of treating of demyelinating diseases or conditions |
| 07/21/2005 | US20050159443 For example, N-[2,4-dichloro-3-(2-methyl-quinolin-8-yloxymethyl)-phenyl]-N-methyl-2-[1-methyl-5-(3-methyl-4-nitro-benzoyl)-1H-pyrrol-2-yl]-acetamide; bradykinin receptor agonists; for treating disorders such as pain, inflammation, asthma and allergy |
| 07/21/2005 | US20050159434 3-{(3R,4R)-4-methyl-3-[methyl-(7H-pyrrolo[2,3-d]pyrimidin-4-yl)-amino]-piperidin-1-yl)-3-oxo-propionitrile mono citrate salt; immunosuppressants, autoimmune diseases, skin disorders, Crohn's disease, antidiabetic agents, anticancer agents, antiarthritic agents |
| 07/21/2005 | US20050159418 Nitrogen compounds used as xanthine oxidase inhibitors, for prophylaxis of inflammation, reperfusion injuries, gout or inflammatory bowel disorders |
| 07/21/2005 | US20050159409 with a hexahydro-5-oxo-4-phenylpyrimido[4,5-b][1,5]diazocine or tetrahydro-5H-pyrimido[4,5-e][1,4]diazepin e ring; treating dysuria, especially increased urinary frequency or incontinence |
| 07/21/2005 | US20050159407 Carboxylic acid substituted heterocycles, derivatives thereof and methods of use |
| 07/21/2005 | US20050159405 Substituted 10-aryl-11h-benzo[b]fluourenes and 7-aryl-5, 6-dihydro-benzo[a]anthracenes for selective effects on estrogen receptors |
| 07/21/2005 | US20050159397 vitamin D3 derivative as anti-cancer agent, for the treatment of skin diseases such as psoriasis as well as skin conditions such as wrinkles, slack skin, dry skin and insufficient sebum secretion, for immune disorders, metabolic bone diseases and also used as antiinflammatory agent |
| 07/21/2005 | US20050159359 Methods and compositions for derepression of IAP-inhibited caspase |
| 07/21/2005 | US20050158406 Methods for treating joint inflammation |
| 07/21/2005 | US20050158358 Tissue engineering scaffolds promoting matrix protein production |
| 07/21/2005 | US20050158357 Polymer tether covalently coupled to the scaffold; and a matrix-enhancing molecule that is covalently coupled to the polymer tether, such as ascorbic acid, angiotensin II, and/or insulin-like growth factor, to elicit production of extracellular matrix by a cell attached to the scaffold |
| 07/21/2005 | US20050158317 Novel proteins with il-6 inhibiting activity |
| 07/21/2005 | US20050158288 Methods of organ regeneration |
| 07/21/2005 | DE20221251U1 Intelligentes, serielles Batterieladegerät und Ladeblock Intelligent, serial battery charger and charging block |
| 07/21/2005 | DE10360835A1 New bicyclic imidazole derivatives are dipeptidylpeptidase-IV inhibitors useful to treat e.g. arthritis, obesity, allograft transplantation and calcitonin-induced osteoporosis |
| 07/21/2005 | CA2552726A1 Cathepsin cysteine protease inhibitors |
| 07/21/2005 | CA2552713A1 Cathepsin cysteine protease inhibitors |
| 07/21/2005 | CA2548990A1 Toll-like receptor 4 (tlr4)-neutralizing antibodies |
| 07/20/2005 | EP1555031A1 Angiogenesis inducer |
| 07/20/2005 | EP1554275A2 Compounds |
| 07/20/2005 | EP1554268A1 Pyrazole inhibitors of the transforming growth factor |
| 07/20/2005 | EP1554256A1 Piperidino pyrimidine dipeptidyl peptidase inhibitors for the treatment of diabetes |
| 07/20/2005 | EP1554245A1 Piperidinetriol derivatives as inhibitors of glycosylceramidsynthase |
| 07/20/2005 | EP1553965A2 Method of treating tumors |
| 07/20/2005 | EP1553958A1 Method of administering bisphosphonates |
| 07/20/2005 | EP1553942A1 Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent |
| 07/20/2005 | EP1553924A1 Novel method of stabilizing diagnostic and therapeutic compounds in a cationic carrier system |
| 07/20/2005 | EP1401467A4 Alpha-fetoprotein peptides and uses thereof |
| 07/20/2005 | EP1303512B1 Process for preparing arylacetylaminothiazoles |
| 07/20/2005 | EP1286673B8 Ligands of integrin receptors |
| 07/20/2005 | EP1272484B1 Benzoamide piperidine compounds as substance p antagonists |
| 07/20/2005 | EP1261328B1 Il-8 receptor antagonists |
| 07/20/2005 | EP1244672B1 4-substituted 7-aza-indolin-2-ones and their use as protein kinase inhibitors |
| 07/20/2005 | EP1198570B1 Monomeric protein of the tgf-beta family |
| 07/20/2005 | EP1189583B1 Indole derivatives |
| 07/20/2005 | EP1175402B1 Piperidine derivatives useful as ccr5 antagonists |
| 07/20/2005 | EP1175401B1 Piperazine derivatives useful as ccr5 antagonists |
| 07/20/2005 | EP1152757B1 Mmp inhibitors in connective tissue softening |
| 07/20/2005 | EP1129077B9 Fluorinated 3,4-dihydroquinoline derivatives used as nos inhibitors |
| 07/20/2005 | EP0910571B1 Novel antiangiogenic peptides, polynucleotides encoding same and methods for inhibiting angiogenesis |
| 07/20/2005 | EP0703785B1 Methods for treating muscle diseases and disorders |
| 07/20/2005 | CN1643138A Novel cytokine ZCYTOR17 ligand |
| 07/20/2005 | CN1643135A Isolated homozygous stem cells differentiated cells derived therefrom and materials and methods for making and using same |
| 07/20/2005 | CN1642983A Antibodies against of C5aR and use thereof |
| 07/20/2005 | CN1642980A Antagonistic anti-hFAS ligand human antibodies and fragments thereof |
| 07/20/2005 | CN1642971A A nucleic acid encoding a G-protein-coupled receptor, and uses thereof |
| 07/20/2005 | CN1642955A Novel alkoxypyridine-derivatives |
| 07/20/2005 | CN1642948A Piperazinyl-, piperidinyl- and morpholinyl-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642944A (3Z) -3-(2, 3-dihydro-1H-ylidene)-1, 3-dihydro-2H-indol-2-ones as kinase inhibitors |
| 07/20/2005 | CN1642943A Synthesis of piperidine and piperazine compounds as CCR5 antagonists |
| 07/20/2005 | CN1642933A Cyclic hemiacetal derivative and use thereof |
| 07/20/2005 | CN1642929A Kappa-opioid receptor agonist comprising 2-phenylbenzothiazoline derivative |
| 07/20/2005 | CN1642918A Novel hererocyclic compound and preparation thereof and medicine composition containing same and use thereof in medicine |
| 07/20/2005 | CN1642912A Sulfonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642907A Carbonylamino-derivatives as novel inhibitors of histone deacetylase |
| 07/20/2005 | CN1642904A Salts of nateglinide |
| 07/20/2005 | CN1642573A Combination of an aldosterone receptor antagonist and a fibric acid derivative |
| 07/20/2005 | CN1642567A HIV inhibiting proteins |
| 07/20/2005 | CN1642559A Combination comprising an HMG-CoA reductase inhibitor and an insulin secretor enhancer or an insulin sensitizer |